-Peroxynitrite is a potent nitrating and oxidizing agent -Peroxynitrite is generated during pathological situations affecting the heart -The caspase-generated RasGAP fragment N has anti-apoptotic properties -Peroxynitrite induces fast cleavage of fragment N and no associated cell protection -A cleavage-resistant form of fragment N inhibits peroxynitrite-induced death 2 Abstract Peroxynitrite (PN) it is a potent nitrating and oxidizing agent generated during various pathological situations affecting the heart. PN negative effects result, at least in part, by its ability to activate caspases and apoptosis. RasGAP is a ubiquitously expressed protein that is cleaved sequentially by caspase-3. At 
Introduction
Peroxynitrite (PN), the product of superoxide-mediated nitric oxide oxidation, has toxic and damaging effects in cells [1] . PN-induced cellular damage is mediated by protein nitration and oxidation of tyrosine residues, anti-oxidant depletion (e.g. inactivation of glutathione peroxidase), and modifications of DNA bases [2] . This impacts on the modulation of several signal transduction pathways including the phosphoinositide 3-kinase/Akt pathway and mitogen activated protein kinase pathways [3, 4] . PN can also lead to executioner caspase activation and apoptosis [5] [6] [7] [8] . PN generation plays an important role in oxidative and nitrosative stress in various patho-physiological situations, including myocardial injury, heart failure and cardiomyopathy [9] .
RasGAP is an ubiquitously expressed, multi-domain protein that acts as a regulator of Ras and Rho GTP-binding proteins. RasGAP contains two conserved caspase-3 cleavage sites [10] . At low caspase-3 activity levels, RasGAP is cleaved at position 455. The resulting N-terminal fragment (fragment N) activates a potent anti-apoptotic-signaling pathway mediated by the Ras/PI3K/Akt pathway [11] , which is crucial for cell survival in low stress conditions [12] . However, at higher caspase 3 activity, fragment N is further cleaved at position 157, abrogating its anti-apoptotic activity [13] . The fragments resulting from this second cleavage (in particular fragment N2
[RasGAP 158-455)]) regulate tumor cell death by sensitizing them to anticancer treatment-induced apoptosis [13] . Therefore RasGAP acts as a sensor of caspase activity that controls the balance between cell death and survival. Over-expression of an uncleavable form of fragment N in vitro protects various cell types against genotoxins, death receptor ligands, UV-c, staurosporine, and inflammatory cytokines [12, 14] . Moreover, transgenic mice expressing fragment N specifically in pancreatic beta cells are more resistant against pro-diabetogenic conditions and their beta cells experience less apoptosis in such situations [15, 16] .
The capacity of fragment N to protect cells against protein nitration-and oxidation-induced death has not been investigated yet. Here, we have evaluated how PN modulates the formation of fragment N and how efficient fragment N was in counteracting PN-induced cell death.
Materials and Methods

Cells
H9C2 cells, a rat heart clonal cell line (ATCC, Manassas, VA) [17] , and HEK 293 cells (ATCC, Manassas, VA catalog n°CRL-1573) were grown in Dulbecco's modified Eagle's medium (DMEM; GIBCO, catalog n°61965) supplemented with 10% fetal calf serum (Invitrogen, catalog n° 41Q2174K), 100 units/ml penicillin, and 0.1 mg/ml streptomycin (Sigma, catalog n° P0781). HeLa cells were maintained in RPMI 1640 (GIBCO catalog n° 61870-10) containing 10% fetal calf serum. All these cells were cultured at 37°C and 5% CO2.
Primary culture of neonatal mouse cardiomyocytes
Hearts were isolated from 1-2 days old new born mice killed by decapitation and placed on ice in ADS buffer [1.1 M NaCl, 1 M Hepes, 0.48 M KCl, 0.1M NaH2PO4 , 0.12 M MgSO47H2O, 0.55 M Glucose). Ventricles without atria were digested in ADS containing 0.45 mg/ml collagenase (Worthington Biochemical Corp.) and 1 mg/ml pancreatin (Invitrogen Corp.) as described [18] . Briefly, the tissue homogenates were incubated for 15 minutes at 37 ºC rocking at 700 rpm. The supernatants were collected and the pellets were subjected to two additional rounds of digestion in 1.5 ml ADS containing collagenase and pancreatin. The supernatants collected out from the three digestion rounds were mixed and plated in 10 cm-culture dishes (10 ventricles per dish) for two rounds of 45 minute-differential plating at 37 ºC and 10% CO2. Cells in the supernatants of the first differential plating were collected and replated for second differential plating. The cells in the supernatants of the second plating were collected, washed once in 5 ml of a 3:1 mixture of DMEM and Medium 199 (Invitrogen) supplemented with 10% horse serum (Oxoid), 5% Fetal Calf Serum (Invitrogen), 100 U/ml penicillin, and 0.1 μg/ml streptomycin centrifuged for 10 minutes at 192 g at room temperature. Seventy-five thousand cells were seeded onto 0.1% gelatincoated 24 well-plates.
Chemicals and Antibodies
Peroxynitrite was supplied as a 50 mM stock in 0.3 M sodium hydroxide, (Cayman Chemicals; catalog n°81565). Hoechst 33342 was from Roche (catalog n°H-1399). It was diluted in water at a final concentration of 10 mg/ml and stored at 4°C in the dark. The anti-RasGAP antibody was from Enzo Life Science (catalog number ALX-210-860-R100) and is directed at the fragment N2 moiety of the human protein (amino acids 158-455). The anti-phospho serine 473-Akt rabbit polyclonal IgG antibody as well as anti caspase-3 monoclonal antibodies were from Cell Signaling Technology (catalog n°9271 and 9665 respectively). The mouse polyclonal IgG antibody recognizing sarcomeric alpha-actinin was from Sigma (catalog n°A78811).
The monoclonal antibody specific for the HA tag was purchased as ascites from Babco (Richmond,CA; catalog n°MMS-101R). This antibody was adsorbed on HeLa cell lysates to decrease non-specific binding as previously described [10] . Secondary antibodies for Western blot were donkey anti- (#14) (previously named HA-GAPN.dn3 and described in [10] ) into the TRIP-PGK-ATGm-MCS-WHV (#349) lentiviral vector opened with the same restriction enzymes. Myr-mAkt1-HA.cmv (#249), which encodes a constitutively active form of Akt that bears a Src myristoylation sequence at its N-terminus and an HA tag at its C-terminus, was described earlier under the name myr-Akt.cmv [11] . Plasmid hIkB alpha delta N2.cmv (#11) encodes the human IkBa protein with the DN2 deletion (i.e. amino acid 3-71); this constructs cannot be phosphorylated by IkB kinases and degraded by the proteasome and therefore functions as an inhibitor of NF-B. It has been described before under the name of IkBαΔN2 [11] . The pEGFP-C1 (#6) plasmid encoding the green fluorescent protein (GFP) is from Clonetech. 
Apoptosis scoring based on nuclear morphology
Apoptosis was determined by scoring the number of cells displaying pycnotic nuclei as described previously [20] .
Apoptosis scoring based on quantitation of cytoplasmic histoneassociated-DNA fragments
Apoptosis was monitored by quantifying the cytoplasmic histone-associated-DNA fragments using cell death detection ELISA plus from Roche (catalog n°1-774-425-001). After the indicated treatments described in Fig The background value was subtracted to all measurements. An enrichment factor, corresponding to the level of mono-and oligo-nucleosomes released to the cytoplasm, was calculated by dividing the corrected absorbance from the experimental conditions with the corrected negative control value.
Stimulation with PN
PN was delivered to the cells as a single bolus at a 1:100 dilution against one side of the dish, while rapidly swirling the medium to ensure optimal exposure of the cells to PN, which was used at final concentrations ranging from 12.5 to 500 μM, which are in agreement with the concentrations of PN used in previous in vitro studies investigating the mechanisms of PN cytotoxicity [4, 17, 21] . Although such concentrations may appear elevated at first glance, it is noteworthy that, due to the rapid decomposition of PN, the cells are actually exposed to lower concentration of this agent. Indeed, it has been determined that bolus addition of 50-500 µM PN to cultured cells resulted in an actual exposure of 5-50 µM of the oxidant. Furthermore, the concentrations of PN used in our study are physiologically relevant, as it has been estimated that the rate of PN generation may reach up to 1 mM min -1 in an inflamed organ such as the lung in vivo.
Lentiviral infection
Recombinant lentiviruses were produced as described previously [14] .
Western blot
Cells were lysed in monoQ-C buffer (70 mM β-glycerophosphate, 0.5% Triton X-100, 2 mM MgCl2, 100 mM Na3VO4, 1 mM dithiothreitol, 20 μg/ml aprotinin) and protein quantification was performed by the Bradford technique. Equal amounts of proteins were subjected to SDS PAGE and then transferred onto a nitrocellulose membrane (Biorad catalog nº162 0115). The membranes were blocked with TBS-Tween 20 0.1% containing 5% non-fat milk and incubated over night at 4°C with the specific primary antibodies.
Blots were then washed with TBS-Tween 0.1%, incubated with the appropriate secondary antibody (1:5000 dilution) 1 hour at room temperature and subsequently visualized and quantified with the Odyssey infrared imaging system (LICOR Biosciences, Bad Homburg, Germany) or with the Chemidoc XRS+ system (Biorad laboratories). In some instances, the blots were stripped and reprobed. This was performed by incubating the blots at 50°C for 30 minutes in stripping buffer (62.5 mM Tris-base, 100 mM -mercaptoethanol, 1% SDS, pH to 6.7) followed by three 20 minute-long washes at room temperature in TBS-tween 0.1%.
Immuno-cytochemistry
Cells were grown on glass coverslips, two days post-infection, the cells were fixed and immuno-cytochemistry was performed as previously described [22] .
Statistical analysis
Results are shown as mean ± 95% confidence intervals. The statistical analyses used in this study were one-way ANOVAs and paired Student's test. In the latter case, the difference between the indicated conditions was considered significant when p < 0.05/n, where p is the probability derived from the t test analysis and n is the number of comparisons done (Bonferroni correction). Statistically significant differences are indicated by asterisks.
Ethics Statement
Experiments on the mice were carried out in strict accordance with the Swiss 
Results
Pattern of PN-induced RasGAP cleavage in H9C2 cells
In order to investigate the pattern of RasGAP cleavage upon PN stimulation, we exposed H9C2 embryonic rat heart myoblast cells [23] to a dose of 250 µM of PN for different periods of time (Fig. 1) . Consistent with previous studies [8] , starting 2 hours post stimulation, PN induced increased levels of caspase-3 activation and apoptotic cell death ( Fig. 1A and C) . This was accompanied by cleavage of RasGAP into fragments N and N2 (Fig. 1B) . In subsequent experiments, the 4 hour post PN stimulation time point was chosen as it allowed PN to efficiently induce its cellular responses.
Exposure of H9C2 cells to increasing doses of PN induced cleavage of caspase-3 activation ( Fig. 2A) and RasGAP into fragment N (Fig. 2B ). This correlated with Akt activity induction (Fig. 2D) . However, there were no conditions where fragment N was produced without a concomitant generation of fragment N2 (Fig. 2B) . Moreover, fragment N production did not correlate with cell survival (Fig. 2C ) and caspase-3 activation (Fig 2A) . These results indicate that PN is not able to induce sequential cleavage of RasGAP and accumulation of fragment N in H9C2 cells that would result in a cell protection response.
Cisplatin induces sequential cleavage of RasGAP in H9C2 cells
The absence of sequential cleavage of RasGAP in PN-treated H9C2 cells could be due to a peculiarity of this cell line. To assess this point, H9C2 cells were treated with increasing doses of cisplatin, which is known to induce sequential cleavage of RasGAP in other cell types [12] . Fig. 3B shows that low concentrations of this genotoxin (< 10 M) led to fragment N generation in H9C2 cells before fragment N2 was substantially produced and that this correlated with cell survival (Fig. 3C ) and mild caspase-3 activation (Fig. 3A) .
Akt stimulation in these conditions was not increased (Fig. 3D) . At higher concentrations of cisplatin (>10 M), fragment N2 levels markedly increased (Fig. 3B ), caspase-3 was strongly activated (Fig. 3A) , levels of active Akt decreased (Fig. 3D) , and apoptosis occurred (Fig. 3C ). These results demonstrate that partial cleavage of RasGAP into the anti-apoptotic RasGAP fragment N can occur in H9C2 cells as seen in other cells types [12] .
PN induces RasGAP cleavage in a non-sequential manner
To assess whether the inability of PN to induce a sequential cleavage of 
Ectopic expression of a caspase-resistant form of fragment N protects cardiomyocytes from PN-induced apoptosis
One possiblity to explain the lack of protection mediated by the endogenously generated fragment N in response to PN is its rapid cleavage. Therefore, if fragment N were not to be degraded, it could counteract PN-induced death.
In order to test this possiblity, wild-type fragment N and the uncleavable D157A form were ectopically expressed in H9C2 cells (Fig. 5A ) before challenging them with low and high PN concentrations. As hypothesized, wild-type fragment N was degraded in response to PN stimulation while the cleavage resistant mutant was not ( Fig. 5B and C) . Over-expression of both fragment N forms inhibited caspase-3 activation and apoptosis induced by low PN concentration (50 µM) ( Fig. 5B and D) , although for apoptosis this did not reach statistical significance in the case of wild-type fragment N (Fig. 5D ).
At high PN concentration (250 M), only the D157A fragment N mutant inhibited caspase-3 activation and apoptosis ( One possibility that could explain the differential capacity of wild-type fragment N and the D157 form of the fragment to protect cardiomyocyte is that the former can be cleaved into smaller fragments (e.g. fragment N2) that have been shown to sensitize tumor cells to apoptosis induced by various stimuli [13, 25, 26] . We therefore determined whether fragment N2 can sensitize H9C2 cells, which despite having been immortalized are however not tumor cells [23] , to PN-induced apoptosis. Figure 5F shows that ectopic expression of fragment N2 in H9C2 cells did not modulate their sensitivity to PN-induced death. This indicates that the lower capacity of fragment N to protect cardiomyocyte from PN-induced apoptosis compared to the uncleavable fragment N mutant likely results from its degradation rather than the generation of pro-apoptotic fragments such as N2.
Finally, we investigated whether fragment N was able to protect primary cardiomyocytes, the purity of which was assessed by -actinin staining (Fig.   6A ). Ectopic expression of wild-type fragment N and the D157A caspaseresistant form of the fragment both led to Akt activation in primary cardiomyoctes ( Fig. 6B ; compare the 0 M lanes). Wild-type fragment N inhibited caspase-3 activation in primary cardiomyocytes stimulated with low, but not high, concentrations of PN. In contrast, the D157A fragment N mutant was able to efficiently reduce caspase-3 activation even at high PN concentrations. This ability of the D157A form of fragment N to inhibit caspase-3 activation was associated with a marked reduction in PN-induced primary cardiomyocyte apoptosis ( Fig. 6C-D) . Thus, the pathways activated by fragment N are able to efficiently protect cardiac cells from PN-induced cell death.
Discussion
Earlier work has shown that RasGAP is cleaved by caspase-3 sequentially in response to increasing concentrations or doses of stress-inducing agents.
This was seen in different cell types exposed to cisplatin, UV light, Fas ligand and doxorubicin [12, 13] . In contrast we provide evidence here that PN does not promote sequential cleavage of RasGAP regardless of whether the cells used are of cardiomyocyte origin or not. No concentration of PN was found that would lead to the partial cleavage of RasGAP into fragment N and that would be associated with cell survival. Fragment N was generated in cells treated with PN but was apparently immediately degraded further into smaller fragments (N1 and N2) that cannot activate the Akt protective pathway [13] .
When the wild-type form of fragment N was ectopically expressed in cells, it failed to inhibit PN-induced apoptosis and this was associated with its degradation. In contrast, a caspase-resistant form of fragment N efficiently protected immortalized (Fig. 5 ) and primary cardiomyocytes ( PN has a short half life, ~1.9 sec at pH 7.4 [27] , yet it induces potent and adverse effects on cellular processes by modulating signal transduction pathways involving Akt, MAPKs (ERK, c-jun, p38), protein kinase C, and NF-кB (reviewed in [3] ). Moreover, PN has the potential to activate multiple caspases including caspase-2, -3, -6, -7, 8 and -9 and thus the cleavage of key cellular proteins such as poly(ADP-ribose) polymerase and lamins [5] .
Considering these broad effects on multiple cellular targets, it appears that upon PN stimulation, caspase activation is an all-or-nothing phenomenon.
Indeed, PN induces a monophasic caspase-3 activation where fragment N and fragment N2 are concomittantly produced and apoptosis occurs ( Fig. 2   and 4 ). This contrasts with the situation observed with cisplatin that induces a biphasic caspase-3 activation, the first phase (low activation) associated with fragment N production, no formation of fragment N2, and cell survival; the second phase (high activation) associated with fragment N degradation into fragment N2 and apoptosis (Fig. 3) .
Interestingly, Akt, the PI3K effector kinase that has been demonstrated to mediate fragment N-induced anti-apoptotic responses [11, 12, [14] [15] [16] , is strongly activated by PN. The ability of PN to modulate Akt is poorly understood. In some cell types (pheochromocytoma cells, endothelial cells, macrophages), PN was shown to efficiently inhibit Akt, while in others PN exposure resulted in strong stimulation of the kinase (skin fibroblasts, hepatoma cell lines, neural cells) [3, 28] . It is suggested that it is the nitration capacity of PN that induces Akt inhibition while it is its oxidative properties that mediate Akt activation [3, 28] . Our results indicate that cardiomyocytes and HeLa cells fall in the second category as PN activates Akt in these cells.
Nevertheless, activation of Akt by PN in cardiac cells does not impede apoptosis and may therefore represent a futile protection attempt. Yet, expression of a constitutively active form of Akt in cardiomyocytes inhibits apoptosis induced by low concentrations of PN (Fig. 5E ). This could therefore be one mechanism used by fragment N to protect cardiomyocyte when the surrounding concentrations of PN are not too elevated. However, fragment N apparently uses additional means to inhibit apoptosis of cardiomyocytes exposed to high concentrations of PN because the active form of Akt does not inhibit apoptosis in these conditions (Fig. 5E) . Hence, signaling pathway others than, or in parallel to, Akt activation could participate in the protection mediated by caspase-resistant forms of fragment N in cardiac cells. The NF-кB transcription factor is a downstream target of Akt [29, 30] . However, in the presence of fragment N, Akt-mediated NF-кB activation is inhibited [11, 14, 16] . NF-B activation leads to cell death of beta cells [31] and the KB epithelial carcinoma cell line [32] . In the heart the role of NF-B is controversial as it may convey both pro-and anti-apoptotic signals [33] .
Nevertheless, recent data are consistent with a detrimental role of NF-B in heart failure [34] . NF-B inhibition might be the other signaling event required
for fragment N to protect cardiomyocytes as recently shown in pancreatic beta cells [16] . However, inhibition of the NF-B pathway did not alter cardiac cell apoptosis induced by either low or high concentrations of PN (Fig. S1 ).
This would suggest that fragment N does not use its NF-B inhibitory capacity to protect cardiomyocytes against PN-induced death. It cannot however be excluded that it is the interplay between Akt activation and NF-B inhibition generated by fragment N that induces a more potent survival response than when Akt and NF-B are regulated separately. The protective pathways regulated by fragment N need to be better characterized as they represent potential targets for the development of cardiac protective therapies.
The loss of adult cardiomyocytes by necrosis or apoptosis is a major factor in the initiation and progression of heart failure as it contributes to the decline in myocardium function [35] . This process is mediated at least in part by PN, which has emerged as a key mediator of cardiomyocyte injury in numerous cardiac pathologies, including myocardial ischemia reperfusion injury, myocarditis, cardiac allograft rejection and anthracycline-induced cardiomyopathy (see [28] for an extended review on this topic). In such conditions, multiple molecular mechanisms have been shown to contribute to peroxynitrite-mediated cytotoxicity, ultimately resulting in the demise of cardiac myocytes, both via the necrotic and apoptotic pathways [10] .
Therefore, in light of our current in vitro findings, future in vivo studies should be designed to assess the importance of fragment N cleavage by PN as a contributing mechanism to cardiomyocyte death in the aforementioned pathological conditions. HeLa cells were treated and analyzed as described for H9C2 cells in Fig. 2 . 
